2024 Market Report by Kings Research "Protein Sequencing Market Size, Share and Ranking, Overall Sales and Demand Forecast 2024-2031" provides an extensive examination of Protein Sequencing Market attributes, size assessments, and growth projections through segmentation, regional analyses, and country-specific insights, alongside a scrutiny of the competitive landscape, player market shares, and essential business strategies

Protein Sequencing Market Size was valued at USD 1231.5 million in 2023 and is projected to grow from USD 1,279.9 million in 2024 to USD 1,743.8 million by 2031, exhibiting a CAGR of 4.52% during the forecast period. 

Discover Key Industry Trends @ https://www.kingsresearch.com/protein-sequencing-market-1631

Key Companies in Protein Sequencing Market:

  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Shimadzu Corporation
  • Rapid Novor, Inc.
  • Charles River Laboratories International, Inc.
  • Proteome Factory AG
  • Merck KGaA
  • Bruker Corporation
  • Fujifilm Holdings Corporation
  • Bio-Rad Laboratories, Inc.
  • Bioinformatics Solutions Inc.
  • PerkinElmer, Inc.
  • Oxford Nanopore Technologies plc
  • Waters Corporation
  • QIAGEN N.V.

In January 2025, Illumina, Inc., in partnership with deCODE Genetics, Standard BioTools, Tecan, GSK, Johnson & Johnson, and Novartis, launched a pilot proteomics program to analyze 50,000 UK Biobank samples. This initiative centers on Illumina’s forthcoming proteomics assay, Illumina Protein Prep, which utilizes SOMAmer technology. This next-generation sequencing (NGS)-based solution aims to enhance scalability in proteomic research, providing broader access to in-depth protein analysis.

North America: Dominated the market in 2023, attributed to the presence of major biotechnology and pharmaceutical companies, advanced healthcare infrastructure, and significant investments in research and development. The region is expected to maintain a substantial market share, estimated between 35-40%.

Opportunities:

Advancements in Proteomics Research: Continuous research is expanding the applications of protein sequencing in drug discovery, disease diagnosis, and personalized medicine.

Growing Demand for Personalized Medicine: Detailed understanding of protein sequences aids in developing targeted therapies, enhancing treatment efficacy.

Expansion in Drug Development: Protein sequencing plays a crucial role in identifying drug targets and biomarkers, streamlining the drug development process.

 Market Segmentation

By Product & Service (Instruments, Reagents & Consumables, Software, and Services)

By Technology (Mass Spectrometry, Edman Degradation, and Hybrid Approaches)

By Application (Biopharmaceuticals, Academic & Research Institutes, Clinical Diagnostics, and Others)

Conclusion

The protein sequencing market is poised for substantial growth, propelled by technological innovations, strategic acquisitions, and a global emphasis on personalized medicine. Addressing existing challenges and leveraging emerging opportunities will be crucial for stakeholders aiming to capitalize on the market's potential.

Related Reports and Latest Industry Development News:

HENNGE Leads Investment in ASPM Provider IssueHunt Inc.

NEC Orchestrating Future Fund begins Invest in Rescale

SB Technology Corp. launches the Cloudflare WAF service